Jeffrey Miner
Founder chez Viscient Biosciences LLC
Fortune : - $ au 31/03/2024
Profil
Jeffrey N.
Miner is the founder of Viscient Biosciences LLC, which is founded in 2017, where he holds the title of Chief Scientific Officer.
He held the position of Senior Director at Ardea Biosciences, Inc. from 2008 to 2013, Executive Director at AstraZeneca LP from 2013 to 2017, and Head-Molecular & Cellular Biology at Ligand Pharmaceuticals, Inc. from 1993 to 2007.
He is currently the Chief Scientific Officer at Organovo Holdings, Inc., a position he has held since 2020 and will hold until 2023.
Dr. Miner received his doctorate from Oregon State University in 1989 and his undergraduate degree from The College of Idaho, Inc. in 1984.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORGANOVO HOLDINGS, INC.
-.--% | 05/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jeffrey Miner
| Sociétés | Poste | Début |
|---|---|---|
Viscient Biosciences LLC
 Viscient Biosciences LLC BiotechnologyHealth Technology Viscient Biosciences LLC engages in the provision of biotechnology services. It works at the intersection of three dimensional tissue technology and multi-omics analysis to discover and develop drugs across range of therapeutic areas. The company was founded by Keith Murphy and Jeffrey N. Miner and is headquartered in San Diego, CA. | Founder | 01/01/2017 |
Anciens postes connus de Jeffrey Miner
| Sociétés | Poste | Fin |
|---|---|---|
| ORGANOVO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 25/08/2023 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Director/Board Member | 01/01/2017 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Director/Board Member | 01/01/2013 |
| LIGAND PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/01/2007 |
Formation de Jeffrey Miner
| Oregon State University | Doctorate Degree |
| The College of Idaho, Inc. | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
Viscient Biosciences LLC
Viscient Biosciences LLC BiotechnologyHealth Technology Viscient Biosciences LLC engages in the provision of biotechnology services. It works at the intersection of three dimensional tissue technology and multi-omics analysis to discover and develop drugs across range of therapeutic areas. The company was founded by Keith Murphy and Jeffrey N. Miner and is headquartered in San Diego, CA. | Health Technology |
